Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Awadhesh Kumar

Showing results (41-50 of 427) with videos related to

Pageof 43
Sort By:
Expert Review of Clinical Pharmacology|December 15, 2015
Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin: rationale and evidencesAwadhesh Kumar Singh, Ritu Singh
Indian Journal of Endocrinology and Metabolism|February 24, 2016
Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative reviewAwadhesh Kumar Singh, Ritu Singh
Indian Journal of Endocrinology and Metabolism|March 3, 2015
Metformin in gestational diabetes: An emerging contenderAwadhesh Kumar Singh, Ritu Singh
Diabetes & Metabolic Syndrome|June 29, 2020
Letter to the editor in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)"Awadhesh Kumar Singh, Ritu Singh
World Journal of Diabetes|July 8, 2022
Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitorsAwadhesh Kumar Singh, Ritu Singh
Indian Journal of Endocrinology and Metabolism|April 5, 2016
Sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors combination therapy in type 2 diabetes: A systematic review of current evidenceAwadhesh Kumar Singh, Ritu Singh
Indian Journal of Endocrinology and Metabolism|July 2, 2016
Triglyceride and cardiovascular risk: A critical appraisalAwadhesh Kumar Singh, Ritu Singh
Expert Review of Clinical Pharmacology|January 26, 2017
SAVOR-TIMI to SUSTAIN-6: a critical comparison of cardiovascular outcome trials of antidiabetic drugsAwadhesh Kumar Singh, Ritu Singh
Diabetes & Metabolic Syndrome|May 11, 2020
Editorial: Herd mentality, herds of migrants/people, and COVID-19 in IndiaAwadhesh Kumar Singh, Anoop Misra
Diabetes & Metabolic Syndrome|April 18, 2020
Reply to Sodium-glucose co-transporter-2 inhibitors, cardiovascular outcomes and the impact of gender: Class effect or statistical play of chance?Awadhesh Kumar Singh, Ritu Singh
Pageof 43

Showing results (41-50 of 427) with videos related to

Sort By:
Pageof 43
Expert Review of Clinical Pharmacology|December 15, 2015
Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin: rationale and evidencesAwadhesh Kumar Singh, Ritu Singh
Indian Journal of Endocrinology and Metabolism|February 24, 2016
Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative reviewAwadhesh Kumar Singh, Ritu Singh
Indian Journal of Endocrinology and Metabolism|March 3, 2015
Metformin in gestational diabetes: An emerging contenderAwadhesh Kumar Singh, Ritu Singh
Diabetes & Metabolic Syndrome|June 29, 2020
Letter to the editor in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)"Awadhesh Kumar Singh, Ritu Singh
World Journal of Diabetes|July 8, 2022
Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitorsAwadhesh Kumar Singh, Ritu Singh
Indian Journal of Endocrinology and Metabolism|April 5, 2016
Sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors combination therapy in type 2 diabetes: A systematic review of current evidenceAwadhesh Kumar Singh, Ritu Singh
Indian Journal of Endocrinology and Metabolism|July 2, 2016
Triglyceride and cardiovascular risk: A critical appraisalAwadhesh Kumar Singh, Ritu Singh
Expert Review of Clinical Pharmacology|January 26, 2017
SAVOR-TIMI to SUSTAIN-6: a critical comparison of cardiovascular outcome trials of antidiabetic drugsAwadhesh Kumar Singh, Ritu Singh
Diabetes & Metabolic Syndrome|May 11, 2020
Editorial: Herd mentality, herds of migrants/people, and COVID-19 in IndiaAwadhesh Kumar Singh, Anoop Misra
Diabetes & Metabolic Syndrome|April 18, 2020
Reply to Sodium-glucose co-transporter-2 inhibitors, cardiovascular outcomes and the impact of gender: Class effect or statistical play of chance?Awadhesh Kumar Singh, Ritu Singh
Pageof 43